(Q28187137)
Statements
A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial (English)
0 references
August 2001
0 references
142
0 references
2
0 references
244-7
0 references